ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 965,07
0,64%
Dow Jones
38 225,66
0,85%
DAX
17 982,07
0,43%
Brent Oil
83,835
0,25%
Bitcoin
59 044,97
-0,13%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Xencor Inc (XNCR)

  7. Xencor Inc (XNCR) Actualités

XNCR Xencor Inc

23,63
0,00 (0,00%)
Avant marché
Dernière mise à jour : 02:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Xencor Inc XNCR NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 23,63 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
23,63
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
09/4/202414:01BWXencor Appoints Bart Cornelissen as Chief Financial Officer
11/3/202420:47EDGAR2Form 144 - Report of proposed sale of securities
11/3/202420:45EDGAR2Form 144 - Report of proposed sale of securities
11/3/202420:40EDGAR2Form 144 - Report of proposed sale of securities
11/3/202420:40EDGAR2Form 144 - Report of proposed sale of securities
07/3/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202420:39EDGAR2Form 144 - Report of proposed sale of securities
06/3/202414:32EDGAR2Form 8-K - Current report
05/3/202422:48EDGAR2Form 144 - Report of proposed sale of securities
05/3/202422:34EDGAR2Form 144 - Report of proposed sale of securities
05/3/202422:27EDGAR2Form 144 - Report of proposed sale of securities
28/2/202422:01BWXencor to Present at Upcoming Investor Conferences
27/2/202422:05EDGAR2Form 8-K - Current report
27/2/202422:01BWXencor Reports Fourth Quarter and Full Year 2023 Financial..
20/2/202422:31BWXencor to Host Webcast to Review Fourth Quarter and Full..
16/2/202423:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
16/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202400:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202420:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:07EDGAR2Form 144 - Report of proposed sale of securities
03/1/202422:01BWXencor to Present at the 42nd Annual J.P. Morgan Healthcare..
02/1/202414:01BWDane Leone Joins Xencor as Senior Vice President, Corporate..
29/12/202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202321:28EDGAR2Form 144 - Report of proposed sale of securities
21/11/202322:01BWXencor to Present at the Piper Sandler 35th Annual..
15/11/202322:02EDGAR2Form 8-K - Current report
07/11/202322:04EDGAR2Form 8-K - Current report
07/11/202322:03EDGAR2Form 8-K - Current report
07/11/202322:01BWXencor Reports Third Quarter 2023 Financial Results
03/11/202317:01BWXencor Presents Preclinical Data from Multiple XmAb®..
31/10/202321:01BWXencor to Host Third Quarter 2023 Financial Results Webcast..
26/10/202314:11EDGAR2Form 8-K - Current report
26/10/202314:01BWXencor Announces Planned Retirement of Chief Financial..
27/9/202315:01BWXencor to Present Multiple Posters at the SITC Annual..
19/9/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202322:31EDGAR2Form 8-K - Current report
19/9/202322:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/9/202322:01BWXencor Appoints Barbara J. Klencke, M.D., to Board of..
03/8/202323:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:02EDGAR2Form 8-K - Current report
03/8/202322:01BWXencor Reports Second Quarter 2023 Financial Results
27/7/202314:01BWXencor to Host Second Quarter 2023 Financial Results Webcast..
03/7/202313:16EDGAR2Form 8-K - Current report
31/5/202300:01BWXencor Presents Clinical Results from Phase 1a Study of..
08/5/202322:01BWXencor Reports First Quarter 2023 Financial Results

Dernières Valeurs Consultées

NASDAQ
XNCR
Xencor
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés